Subscribe
olivier-le-moal-shutterstock-com
Olivier Le Moal / Shutterstock.com
2 November 2015Americas

Fitbit requests triple damages in patent lawsuit

Wearable technology company Fitbit has accused competitor Aliphcom of infringing a number of its patents covering devices that record an individual’s fitness.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Jawbone’s patents cover ‘ineligible subject matter’, ITC says
7 March 2016   The International Trade Commission has invalidated two patents owned by Jawbone because they cover “ineligible subject matter”, dealing a blow to the wearable fitness company in its legal battle with rival Fitbit.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Americas
Jawbone’s patents cover ‘ineligible subject matter’, ITC says
7 March 2016   The International Trade Commission has invalidated two patents owned by Jawbone because they cover “ineligible subject matter”, dealing a blow to the wearable fitness company in its legal battle with rival Fitbit.

More on this story

Americas
Jawbone’s patents cover ‘ineligible subject matter’, ITC says
7 March 2016   The International Trade Commission has invalidated two patents owned by Jawbone because they cover “ineligible subject matter”, dealing a blow to the wearable fitness company in its legal battle with rival Fitbit.

More features

GSK triumphs in EPO appeal, revoking Pfizer patent
‘We took Ravgen head-on’: How we won zero-damages and others didn't
Kathi Vidal to leave USPTO ahead of incoming Trump administration
Herbert Smith Freehills and Kramer Levin in $2bn merger talks
Teva fights for re-listing of inhaler patents at US appeals court
CRISPR patents revoked following Nobel Prize winners’ withdrawal
White & Case hires experienced litigator from A&O Shearman
President Trump 2.0: Five major areas to watch